Skip to content

Poster Sessions 1-2

Thursday, 2 November
Start time: 10:30 am End time: 11:10 am
E-Poster Area
POSTER SESSION 1 (10:30-10:50)

Station 1: Beneficial Effect Of Resveratrol To Inhibit Pathological Myofibroblast Differentiation Of Valvular Interstitial Cell In Experimental Heart Valve Model
Station 2: Adherence To Benzathine Prophylaxis Among Rheumatic Fever And Rheumatic Heart Disease Patients Attending An Outpatient Clinic At Lira Regional Referral Hospital, Uganda
Station 3: Immune System Activation In Rheumatic Heart Disease
Station 4: Improvised Tricuspid Annuloplasty During Left-Side Valve Surgery Caused By Rheumatic Heart Disease
Station 5: Doctors With Borders: The Impact Of International Travel Bans On Timorese Citizens Awaiting Cardiac Intervention
Station 6: Echocardiographic Profile Of Children With Rheumatic Heart Disease At Tertiary Cardiac Center Of Nepal
Station 7: Echocardiographic Screening For Rheumatic Heart Disease In Rural Cameroonian School Children
Station 8: A Snowball Approach For Screening Of Asymptomatic Rheumatic Heart Disease Among School Age Children In Ethiopia: A Comparative Cross-Sectional Study
Station 9: Rheumatic Heart Disease And Echo-Based Screening: A Four-Year Audit Of Suva School Program From 2018-2021
Station 10: Factors Associated With Severity Of Rheumatic Heart Disease Among Patients In Moi Teaching And Referral Hospital, Kenya, 2020
Station 12: Mean Level Of B-Type Natriuretic Peptide (BNP) In Patients With Mitral Stenosis Caused By Rheumatic Heart Disease
Station 13: Use Of Alternative Drugs For Rheumatic Fever Prophylaxis In Place Of Injection Benzathine Penicillin
Station 14: Investigating Benzathine Penicillin Prophylaxis In Rheumatic Heart Disease Mortality: A Verbal Autopsy Study

POSTER SESSION 2 (10:50-11:10)

Station 1: Rheumatic Heart Disease (RHD) Burden In Australia: Results And Learnings From Use Of Person-Linked Multi-Jurisdictional Data
Station 2: Preoperative Left Ventricular Dysfunction Is A Risk Factor For Late Death In Paediatric Patients After Rheumatic Heart Disease Surgery For Isolated Aortic Valve Disease
Station 3: Rapid Molecular Point-Of-Care Test For Strep A Pharyngitis In Remote-Living School Aged Children
Station 4: The Gap Between Knowledge And Action: Understanding Community Behaviour Around Management Of Pediatric Sore Throats In Uganda
Station 5: A Health Technology Landscape Assessment For A Novel M-Health Approach For Managing Rheumatic Heart Disease: Lessons From The Act Application
Station 6: The Gap Between Knowledge And Action: Understanding Frontline Health Care Provider Management Practices Of Pediatric Sore Throats In Uganda
Station 7: Assessment Of Improvement In Left Atrial Volume Index After Percutaneous Transvenous Mitral Commissurotomy
Station 8: Serum FCN-3 Protein As A Potential Biomarker In Assessing Rheumatic Heart Disease
Station 9: Oral Anticoagulation For Atrial Fibrillation In Rheumatic Heart Disease
Station 10: Prevalence And Predictors Of Outcome In Patients With Predominant Rheumatic Mitral Stenosis In Eastern Nepal
Station 11: End-User Experience Of The 2012 Whf Echocardiographic Criteria For Diagnosis Of Rheumatic Heart Disease – A Global Survey
Station 12: Insights Into The Mechanisms Of Left Ventricular Dysfunction Through Assessment Of Diastolic Flow In Patients With Mitral Stenosis Using 3D Echocardiography
Station 13: Circulating Serum Levels Of Group A Streptococcal Antibodies In RHD